OBJECTIVE CRITERIA FOR EVALUATION OF THE DESTRUCTIVE PROCESSES INTENSITY IN CHRONIC DERMATOSIS (COMMUNICATION 2)

E. N Volkova , E. A Korotkaya , S. G Morozov , I. V Elistratova

Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (2) : 40 -44.

PDF
Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (2) :40 -44. DOI: 10.17816/dv36669
Articles
research-article

OBJECTIVE CRITERIA FOR EVALUATION OF THE DESTRUCTIVE PROCESSES INTENSITY IN CHRONIC DERMATOSIS (COMMUNICATION 2)

Author information +
History +
PDF

Abstract

The authors present an algorithm of measurements of immunity values in patients with chronic dermatoses for evaluation of the destructive processes by the activity of leukocytic elastase.

Keywords

atopic dermatitis / destructive processes / leukocytic elastase / alpha proteinase inhibitor

Cite this article

Download citation ▾
E. N Volkova, E. A Korotkaya, S. G Morozov, I. V Elistratova. OBJECTIVE CRITERIA FOR EVALUATION OF THE DESTRUCTIVE PROCESSES INTENSITY IN CHRONIC DERMATOSIS (COMMUNICATION 2). Russian Journal of Skin and Venereal Diseases, 2012, 15(2): 40-44 DOI:10.17816/dv36669

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Aldonyte R., Hutchinson T.E., Jin B. et al. // COPD. — 2008. — Vol. 5, N 3. — Р. 153—162.

[2]

Billing A.G., Jochum M., Frohlich D. et al. // Eur. J. Clin. Invest. — 1997. — Vol. 27. — P. 1030—1037.

[3]

Brown A., Farmer K., MacDonald L. // Am. J. Respir. Cell Mol. Biol. — 2003. — Vol. 29. — P. 381—389.

[4]

Cork M.J., Robinson D.A., Vasilopoulos Y. et al. // J. Allergy Clin. Immunol. — 2006. — Vol. 118. — P. 3—21.

[5]

Custovic A., Taggart S., Francis H. // J. Allergy Clin. Immunol. — 1996. — Vol. 98. — P 64—72.

[6]

Dallergi F., Ottonello L. // Inflamm. Res. — 1997. — Vol. 46. — P. 382—391.

[7]

Ide H., Itoh H., Yoshida E. et al. // Cell Tissue Res. — 1999. — Vol. 297. — P. 149—154.

[8]

Kiehl P., Falkenberg K., Vogelbruch M. et al. // Br. J. Dermatol. — 2001. — Vol. 145. — P. 720—729.

[9]

Lee S.H., Jeong S.K., Ahn S.K. // Yonsei Med. J. — 2006. — Vol. 47. — P. 293—306.

[10]

Mägert H.J., Drögemüller K., Raghunath M. // Curr. Protein Pept. Sci. — 2005. — Vol. 6, N 3. — P. 241—254.

[11]

Meyer-Hoffert U. // Arch. Immunol. Ther. Exp. — 2009. — Vol. 57. — P. 345—354.

[12]

Neshkova E., Puzhko S., Dotsenko V. et al. // J. Immunopharmacol. — 1996. — Vol. 33. — P. 383—386.

[13]

Pratt C.W., Pizzo S.V // Biochemistry. — 1987. — Vol. 26. — P. 2855—2863.

[14]

Salier J.P., Rouet P., Raguenez G. et al. // Biochem. J. — 1996. — Vol. 315. — P. 1—9.

[15]

Sporik R., Holgate S.T., Platts-Mills T.A.E. et al. // N. Engl. J. Med. — 1990. — Vol. 323. — P. 502—507.

[16]

Takahashi H., Nukiwa T., Yoshimura K. et al. // J. Biol. Chem. — 1988. — Vol. 263, N 29. — P. 14739—14747.

[17]

Tsujii T., Katayama K., Naito I., Seno S. // Histochemistry. — 1988. — Vol. 88, N 3—6. — P. 443—451.

[18]

Vogelmeier C., Biedermann T., Maier K. et al. // Eur. Respir. J. — 1997. — Vol. 10. — P. 2114—2119.

[19]

Wiedow O., Muhle K., Streit V et al. // Biochim. Biophys. Acta. — 1996. — Vol. 1315. — P. 185—187.

[20]

Wiedow O., Wiese F., Streit V. et al. // J. Invest. Dermatol. — 1992. — Vol. 99. — P. 306—309.

RIGHTS & PERMISSIONS

Eco-Vector

PDF

82

Accesses

0

Citation

Detail

Sections
Recommended

/